Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Packaging
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Analysis

Stefan Rampf to take over as CFO at Rentschler on 1 May

1-Mar-2016
Manufacturing | Pharmaceutical

He will be responsible for commercial management

Rentschler Biotechnologie, a German contract development and manufacturing organisation, says Stefan Rampf will become the firm's new Chief Financial Officer (CFO) on 1 May.

Sign up for your free email newsletter

Rampf will be responsible for commercial management. He has around 10 years' experience as CFO with a number of firms, most recently with ABL Technik Entlackung, Leutkirch, and, until 2013, with Volvo Financial Services in Frankfurt.

Companies

  • Rentschler Group

Related Content

Rentschler Biopharma strengthens leadership team
Rentschler Biopharma strengthens leadership team
Rentschler Biopharma continues hiring at global sites
Rentschler Biopharma continues hiring at global sites
Rentschler Biotechnologie announces transition into EU corporation
Rentschler Biotechnologie announces transition into EU corporation
Leukocare to be technology partner for Rentschler’s biopharmaceuticals
Leukocare to be technology partner for Rentschler’s biopharmaceuticals
Rentschler expands cGMP manufacturing capacity following increased international demand
Rentschler expands cGMP manufacturing capacity following increased international demand
Rentschler doubles manufacturing capacity to address growing demand for biopharmaceuticals
Rentschler doubles manufacturing capacity to address growing demand for biopharmaceuticals
4th Laupheim Biotech Days
4th Laupheim Biotech Days
Frank Mathias to become CEO of Rentschler Biotechnologie
Frank Mathias to become CEO of Rentschler Biotechnologie
Rentschler Biotechnologie expands European manufacturing capabilities with GE bioprocess technologies
Rentschler Biotechnologie expands European manufacturing capabilities with GE bioprocess technologies
Rentschler commissions new 2,000L single-use bioreactor
Rentschler commissions new 2,000L single-use bioreactor
Employing new single-use technology in bioprocesses
Employing new single-use technology in bioprocesses
Rentschler invests €24m in stainless steel bioreactor manufacturing
Rentschler invests €24m in stainless steel bioreactor manufacturing
Rentschler to expand single-use manufacturing capacities
Rentschler to expand single-use manufacturing capacities
Processes for Virus-based Biologics
Processes for Virus-based Biologics
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company